178 filings
Page 2 of 9
PRE 14A
RNAZ
TransCode Therapeutics Inc
Preliminary proxy
8 Dec 23
4:57pm
8-K
RNAZ
TransCode Therapeutics Inc
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:56pm
SC 13G
RNAZ
TransCode Therapeutics Inc
7 Dec 23
Transcode Therapeutics / Lind Global Fund II ownership change
4:30pm
8-K
RNAZ
TransCode Therapeutics Inc
4 Dec 23
TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
5:07pm
424B5
RNAZ
TransCode Therapeutics Inc
1 Dec 23
Prospectus supplement for primary offering
5:23pm
8-K
RNAZ
TransCode Therapeutics Inc
14 Nov 23
TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
4:40pm
10-Q
2023 Q3
RNAZ
TransCode Therapeutics Inc
Quarterly report
14 Nov 23
12:00am
8-K
RNAZ
TransCode Therapeutics Inc
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
RNAZ
TransCode Therapeutics Inc
27 Oct 23
Nasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions
4:06pm
424B5
RNAZ
TransCode Therapeutics Inc
26 Oct 23
Prospectus supplement for primary offering
4:29pm
8-K
RNAZ
TransCode Therapeutics Inc
24 Oct 23
TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138
8:05am
SC 13D/A
Robert Michael Dudley
10 Oct 23
Transcode Therapeutics / Dudley Robert Michael ownership change
4:00pm
4
Thomas A Fitzgerald
2 Oct 23
Transcode Therapeutics / Thomas A Fitzgerald ownership change
4:39pm
4
Robert Michael Dudley
2 Oct 23
Transcode Therapeutics / Robert Michael Dudley ownership change
4:37pm
8-K
RNAZ
TransCode Therapeutics Inc
28 Sep 23
TransCode Therapeutics Announces Pricing of $8 Million Public Offering
4:07pm
424B4
RNAZ
TransCode Therapeutics Inc
27 Sep 23
Prospectus supplement with pricing info
5:26pm
SC 13G
RNAZ
TransCode Therapeutics Inc
26 Sep 23
Transcode Therapeutics / TANG CAPITAL PARTNERS ownership change
11:06am
EFFECT
RNAZ
TransCode Therapeutics Inc
26 Sep 23
Notice of effectiveness
12:15am
CORRESP
RNAZ
TransCode Therapeutics Inc
25 Sep 23
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
25 Sep 23
Correspondence with SEC
12:00am